Muscle specific gene targeting of mTORC1 components induces myopathy [63,64] and overexpression of integrin α7 can improve the dystrophic phenotype through increased survival signaling via p70S6K [65], suggesting that p70S6K inhibition would not be advantageous. The gene discussed is RPS6KB1; the disease is myopathy.